Effective Stimulant Medications for Managing ADHD
Methylphenidate and amphetamine-based medications are the most effective first-line stimulant treatments for ADHD, with an effect size of approximately 1.0, significantly higher than non-stimulant alternatives (effect size ~0.7). 1, 2
First-Line Stimulant Options
Methylphenidate Formulations
- Immediate-release (IR): Starting dose 5 mg twice daily (before breakfast and lunch); increase by 5-10 mg weekly; maximum 60 mg daily 3
- Extended-release (ER): Various formulations available with 8-12 hour duration:
Amphetamine Formulations
- Lisdexamfetamine (Vyvanse): Prodrug formulation with longer duration of action 7
- Mixed amphetamine salts (Adderall): Available in immediate and extended-release forms
Choosing Between Stimulant Classes
- Response to methylphenidate versus amphetamine is idiosyncratic:
- Approximately 40% of patients respond to both medications
- About 40% respond to only one of the medication classes 1
- ADHD subtype does not predict response to a specific agent 1
- If one stimulant class is ineffective or causes intolerable side effects, try the other class
Dosing Considerations
- Start with low doses and titrate gradually:
- Extended-release formulations offer advantages:
Monitoring and Side Effects
- Common side effects include:
- Regular monitoring recommended for:
- Vital signs (heart rate, blood pressure)
- Weight and height (in children)
- Emergence of tics or psychiatric symptoms 2
Special Populations
Preschool-Aged Children (4-6 years)
- Methylphenidate is the recommended first-line medication for preschool children with moderate-to-severe ADHD who don't respond to behavioral therapy 1
- Use caution: increased risk of mood lability and dysphoria 1
Children and Adolescents
- Stimulants have robust evidence for efficacy in reducing core ADHD symptoms 1
- Monitor growth as stimulants may affect height and weight gain 1
Adults
- Stimulants remain highly effective for adult ADHD 1
- Dosing typically divided 2-3 times daily for immediate-release formulations 3
Second-Line Options (Non-Stimulants)
If stimulants are ineffective or contraindicated, consider:
- Atomoxetine: Selective norepinephrine reuptake inhibitor 1, 8
- Extended-release guanfacine or clonidine: Alpha-2 adrenergic agonists 1, 8
- These medications have lower efficacy (effect size ~0.7) compared to stimulants (effect size ~1.0) 1
Important Contraindications
- Known hypersensitivity to the medication 3, 7
- Concurrent use of MAOIs or within 14 days of discontinuation 3, 7
- Caution in patients with:
Clinical Pearl
When initiating stimulant therapy, an individual's response cannot be predicted by weight or plasma concentrations. Therefore, careful titration to find the optimal dose that maximizes benefits while minimizing side effects is essential 5.